Trials / Sponsors / Noorik Biopharmaceuticals AG
Noorik Biopharmaceuticals AG
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome Hepatorenal Syndrome, Liver Cirrhosis, Acute Kidney Injury | Phase 2 | 2024-04-17 |
| Terminated | A Study of Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19 Covid19, Hypoxemia | Phase 2 | 2021-02-08 |
| Terminated | A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis Cirrhosis, Portal Hypertension, Ascites | Phase 2 | 2019-04-11 |